Published in Am J Physiol Renal Physiol on May 22, 2013
Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis. Am J Respir Crit Care Med (2016) 1.39
Proteinase-activated receptor-2 transactivation of epidermal growth factor receptor and transforming growth factor-β receptor signaling pathways contributes to renal fibrosis. J Biol Chem (2013) 0.99
Sorafenib ameliorates renal fibrosis through inhibition of TGF-β-induced epithelial-mesenchymal transition. PLoS One (2015) 0.80
The ligand-bound thyroid hormone receptor in macrophages ameliorates kidney injury via inhibition of nuclear factor-κB activities. Sci Rep (2017) 0.75
Divergent Inhibitor Susceptibility among Airway Lumen-Accessible Tryptic Proteases. PLoS One (2015) 0.75
Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis (2009) 18.60
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem (2008) 2.09
Enhanced angiotensin receptor-associated protein in renal tubule suppresses angiotensin-dependent hypertension. Hypertension (2013) 1.52
The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. J Biol Chem (2004) 1.40
Oral administration of a novel long-acting prostacyclin agonist with thromboxane synthase inhibitory activity for pulmonary arterial hypertension. Circ J (2013) 1.39
Regulation of prostasin by aldosterone in the kidney. J Clin Invest (2002) 1.33
Palladium(II)-Catalyzed Oxidation of Alcohols to Aldehydes and Ketones by Molecular Oxygen. J Org Chem (1999) 1.28
Differential regulation of Rad18 through Rad6-dependent mono- and polyubiquitination. J Biol Chem (2004) 1.18
Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma. Oncology (2002) 1.13
Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate. J Biol Chem (2010) 1.09
Aberrant ENaC activation in Dahl salt-sensitive rats. J Hypertens (2009) 1.03
Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins. J Am Soc Nephrol (2005) 1.03
Functional characterization of rat organic anion transporter 5 (Slc22a19) at the apical membrane of renal proximal tubules. J Pharmacol Exp Ther (2005) 1.02
Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate disodium. Am J Kidney Dis (2006) 1.02
Identification and characterization of a Kidd antigen/UT-B urea transporter expressed in human colon. Am J Physiol Cell Physiol (2004) 1.01
Unphosphorylated twitchin forms a complex with actin and myosin that may contribute to tension maintenance in catch. J Exp Biol (2007) 1.00
Liddle's syndrome caused by a novel mutation in the proline-rich PY motif of the epithelial sodium channel beta-subunit. J Clin Endocrinol Metab (2004) 0.98
Two male siblings with hereditary renal hypouricemia and exercise-induced ARF. Am J Kidney Dis (2003) 0.97
Mutations in human urate transporter 1 gene in presecretory reabsorption defect type of familial renal hypouricemia. J Clin Endocrinol Metab (2005) 0.97
CD36 is one of important receptors promoting renal tubular injury by advanced oxidation protein products. Am J Physiol Renal Physiol (2008) 0.97
Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension. J Hypertens (2009) 0.95
Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells. Am J Physiol Renal Physiol (2008) 0.95
Transcatheter arterial chemotherapy with and without embolization in patients with hepatocellular carcinoma. Oncology (2004) 0.94
In vivo contribution of serine proteases to the proteolytic activation of γENaC in aldosterone-infused rats. Am J Physiol Renal Physiol (2012) 0.94
An oral adsorbent, AST-120 protects against the progression of oxidative stress by reducing the accumulation of indoxyl sulfate in the systemic circulation in renal failure. Pharm Res (2007) 0.92
Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol (2005) 0.92
Clinical and functional characterization of URAT1 variants. PLoS One (2011) 0.92
Survival and local recurrence rates of hepatocellular carcinoma patients treated by transarterial chemolipiodolization with and without embolization. Hepatol Res (2002) 0.91
Protective effect of vascular endothelial growth factor/vascular permeability factor 165 and 121 on glomerular endothelial cell injury in the rat. Lab Invest (2004) 0.90
The structure and function of oxidized albumin in hemodialysis patients: Its role in elevated oxidative stress via neutrophil burst. Biochem Biophys Res Commun (2005) 0.90
Fibrocystin interacts with CAML, a protein involved in Ca2+ signaling. Biochem Biophys Res Commun (2005) 0.90
Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury. Drug Metab Dispos (2008) 0.89
A novel prostacyclin agonist protects against airway hyperresponsiveness and remodeling in mice. Am J Respir Cell Mol Biol (2012) 0.88
Urinary prostasin in humans: relationships among prostasin, aldosterone and epithelial sodium channel activity. Hypertens Res (2009) 0.88
Inhibition of prostasin secretion by serine protease inhibitors in the kidney. J Am Soc Nephrol (2003) 0.88
Impaired hepatic granuloma formation in mice deficient in C-C chemokine receptor 2. J Pathol (2003) 0.88
Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy. Int J Radiat Oncol Biol Phys (2012) 0.87
Single injection of a sustained-release prostacyclin analog improves pulmonary hypertension in rats. Am J Respir Crit Care Med (2007) 0.87
Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients. Hypertens Res (2005) 0.87
Application of FDG-PET in cervical cancer and endometrial cancer: utility and future prospects. Anticancer Res (2014) 0.87
A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey). Clin Exp Nephrol (2004) 0.86
Inhibition of prostasin expression by TGF-beta1 in renal epithelial cells. Kidney Int (2005) 0.86
Effect of olmesartan on oxidative stress in hemodialysis patients. Hypertens Res (2007) 0.86
Aldosterone requires vasopressin V1a receptors on intercalated cells to mediate acid-base homeostasis. J Am Soc Nephrol (2011) 0.86
Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients. Kidney Int (2004) 0.85
Periodontal disease and hypertriglyceridemia in Japanese subjects: potential association with enhanced lipolysis. Metabolism (2010) 0.85
Sustained-release prostacyclin analog ONO-1301 ameliorates tubulointerstitial alterations in a mouse obstructive nephropathy model. Am J Physiol Renal Physiol (2012) 0.84
Different Mechanisms for the Progression of CKD with ACE Gene Polymorphisms. Nephron Clin Pract (2009) 0.84
Alleviation of cisplatin-induced acute kidney injury using phytochemical polyphenols is accompanied by reduced accumulation of indoxyl sulfate in rats. Clin Exp Nephrol (2011) 0.84